Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)

Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)

Abstract The role of metformin (MET) in the treatment of patients with advanced HFrEF and type 2 diabetes mellitus (DM) is not firmly established. We studied the impact of MET on metabolic profile, quality of life (QoL) and survival in these patients. A total of 847 stable patients with advanced HFr...

Full description

Bibliographic Details
Main Authors: Jan Benes, Martin Kotrc, Katerina Kroupova, Peter Wohlfahrt, Jan Kovar, Janka Franekova, Marketa Hegarova, Lenka Hoskova, Eva Hoskova, Terezie Pelikanova, Petr Jarolim, Josef Kautzner, Vojtech Melenovsky
Format: Article
Language:English
Published: Nature Portfolio 2022-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-17327-4

Internet

https://doi.org/10.1038/s41598-022-17327-4

Similar Items